在自身免疫血液溶解性贫血的表面之下:病原遗传网络,治疗进展和开放的问题
Alessandro Costa1,2, Olga Mulas1,2, Angela Maria Mereu1
1Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Frontiers in immunology
|August 18, 2025
概括
自身免疫性溶血性贫血 (AIHA) 源于免疫失调,而不仅仅是红细胞的破坏. 新疗法针对B细胞,并补充了个性化AIHA治疗的途径.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫性溶血性贫血 (AIHA) 涉及复杂的免疫失调,不仅仅是简单的红细胞破坏.
- 病变发生包括自身反应性淋巴细胞,巨细胞和网状内皮系统,B细胞自身抗体和补体激活具有关键作用.
- AIHA的异质性 (温暖,寒冷的凝聚素疾病/综合征) 决定了不同的治疗反应.
研究的目的:
- 审查AIHA的不断变化的免疫病原发生.
- 检查新兴的治疗策略及其基础的逻辑.
- 讨论这些进展对未来AIHA治疗模式的影响.
主要方法:
- 关于AIHA免疫病原发生的当前文献的综述.
- 对新出现的治疗点和药物进行分析.
- 整合临床数据和机械洞察力.
主要成果:
- 艾哈病原是先天性和适应性免疫的复杂相互作用.
- 新型疗法向补充剂 (例如,抗C1s抗体) 和B细胞受体信号 (例如,BTK,SYK,PI3K抑制剂).
- 这些进展正在将AIHA治疗转向精准医学方法.
结论:
- 了解AIHA免疫病原生成对于开发向疗法至关重要.
- 新兴药物为治疗耐药的AIHA提供了新的希望.
- 由疾病生物学指导的精准医学正在为AIHA重塑治疗格局.
相关概念视频
Autoimmune Disorders
671
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
671
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K


